Janelle Pugashetti, MD

profile-janelle-pugashetti-2022
Assistant Professor of Internal Medicine, Medical School
Available to mentor
Janelle Pugashetti, MD
profile-janelle-pugashetti-2022
Assistant Professor
  • About
  • Qualifications
  • Center Memberships
  • Recent Publications
  • Manage Your Profile

  • About

    Dr. Pugashetti is an Assistant Professor at the University of Michigan, in the Division of Pulmonary and Critical Care. After receiving her undergraduate degree from UCLA, she went on to receive her medical degree, Internal Medicine training, and fellowship in Pulmonary and Critical Care at UC Davis. Dr. Pugashetti has also completed a Master’s Degree in Epidemiology. She joined Michigan Medicine in 2022, where she now provides expert care for patients with interstitial lung disease (ILD) at the Taubman Pulmonary Clinic. She leads the pulmonary presence in the Connective Tissue Disease-Associated ILD Clinic (CTD-ILD) program and she directs the Interstitial Lung Disease program at the Ann Arbor VA.

    Dr. Pugashetti is interested in the intersection between autoimmune disease and lung disease. She is an emerging expert in CTD-ILD and is NIH-funded to study predictive biomarkers to guide therapeutic selection, thereby improving outcomes for patients with CTD-ILD.

    Qualifications

    • Fellowship
      University of California Davis, Pulmonary & Critical Care Medicine, Sacramento, United States
      2019 - 2022
    • Residency
      University of California Davis, Internal Medicine, Sacramento, United States
      2019 - 2019
    • M.S., Epidemiology
      University of California Davis, Sacramento, United States
      2021 - 2022
    • M.D.
      University of California Davis, Sacramento, United States
      2012 - 2016
    • B.S., Psychobiology
      University of California, Los Angeles, Los Angeles, CA, United States
      2007 - 2011

    Center Memberships

    • Center Member
      AI and Digital Health Innovation

    Recent Publications

    See All Publications
    • Journal Article
      Fibrotic Morphology and Survival in Interstitial Pneumonia with Autoimmune Features.
      Jee AS, Pugashetti JV, Yazbeck L, Curnow A, Lee CT, Yu A, Hammoud N, Liu GY, Wang JM, Lynn E, Chua F, White E, O'Dwyer DN, Adams T, Wolters PJ, Strek ME, Adegunsoye A, Newton CA, Molyneaux PL, Oldham JM. Eur Respir J, 2026 Oct 23; DOI:10.1183/13993003.00978-2026
      PMID: 42919640
    • Journal Article
      Mycophenolate and azathioprine in fibrotic interstitial lung disease
      Pugashetti JV, Jee AS, Yu AR, Hammoud N, Chua F, Yazbeck L, Lee CT, Liu GY, Adams TN, Adegunsoye A, Wolters PJ, Khanna D, Strek ME, Oldham JM, Molyneaux PL, Newton CA. American Journal of Respiratory and Critical Care Medicine, 2026 Oct 1; 212 (10): 2493 - 2503. DOI:10.1093/ajrccm/aamag362
      PMID: 42432856
    • Journal Article
      Sex-related transcriptomic differences in idiopathic pulmonary fibrosis
      Menon AA, Moll M, Pugashetti JV, Linderholm AL, Liu GY, Krishna R, Ma SF, Noth I, Hunninghake GM, Feghali-Bostwick C, Ghosh AJ. American Journal of Respiratory and Critical Care Medicine, 2026 Oct 1; 212 (10): 2510 - 2513. DOI:10.1093/ajrccm/aamag080
      PMID: 41738237
    • Journal Article
      Reply to Gogali and Kostikas: Beyond the Average Treatment Effect: Toward Precision Immunosuppression in Fibrotic Interstitial Lung Disease.
      Pugashetti JV, Jee AS, Newton CA. Am J Respir Crit Care Med, 2026 Sep 25; DOI:10.1093/ajrccm/aamag504
      PMID: 42788651
    • Journal Article
      Smoking-Related Clinical and Molecular Abnormalities in Idiopathic Pulmonary Fibrosis—Associated Pulmonary Hypertension
      Zhyvylo I, Sood N, Pugashetti JV, Linderholm AL, Hsu SW, Oldham J, Chen CH, Goncharova EA. Pulmonary Circulation, 2026 Sep 1; 16 (3): DOI:10.1002/pul2.70349
    • Journal Article
      Survival According to Radiomic and Visual Usual Interstitial Pneumonia Classification in Fibrotic Interstitial Lung Disease.
      Wang JM, Pugashetti JV, Thompson J, Kang E, Kazerooni EA, Flaherty KR, Belloli EA, Sheth JS, O'Dwyer DN, Han MK, Hatt CR, Oldham JM, Chung JH. Chest, 2026 Aug 12; DOI:10.1016/j.chest.2026.08.002
      PMID: PMC13494922
    • Journal Article
      Association of Longitudinal Mediastinal Lymph Node Dynamics With Mortality and Fibrosis Progression in Fibrotic Interstitial Lung Disease.
      Adegunsoye A, Oldham JM, Aracena KA, Sickinger D, Ghasemiesfe A, Devaraj A, Pugashetti JV, Lee CT, Udofia I, Ventura IB, Bellam S, Thakrar K, Husain AN, Sperling AI, Noth I, Strek ME, Molyneaux PL, Chelala L, Chung JH. Chest, 2026 Jul 7; DOI:10.1016/j.chest.2026.05.052
      PMID: PMC13639882
    • Journal Article
      A75-25 Immunosuppression in Interstitial Lung Disease: A Multi-center Clone-censor-weighting Analysis
      Pugashetti JV, Jee AS, Yu A, Hammoud N, Chua FJ, Yazbeck L, Lee CT, Liu GY, Adams TN, Adegunsoye AO, Wolters PJ, Strek ME, Oldham J, Molyneaux PL, Newton C. American Journal of Respiratory and Critical Care Medicine, 2026 Jun 24; 212 (Supplement_2): aamag286.168 DOI:10.1093/ajrccm/aamag286.168